These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1397 related items for PubMed ID: 21885145

  • 1. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A, Dubray B, Doyeux K, Back A, Hapdey S, Modzelewski R, Bohn P, Gardin I, Vera P.
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P, Bohn P, Edet-Sanson A, Salles A, Hapdey S, Gardin I, Ménard JF, Modzelewski R, Thiberville L, Dubray B.
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [Abstract] [Full Text] [Related]

  • 3. Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans.
    Aristophanous M, Yong Y, Yap JT, Killoran JH, Allen AM, Berbeco RI, Chen AB.
    Radiother Oncol; 2012 Mar; 102(3):377-82. PubMed ID: 22265731
    [Abstract] [Full Text] [Related]

  • 4. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J, Thureau S, Dubray B, Modzelewski R, Thiberville L, Gardin I, Vera P.
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [Abstract] [Full Text] [Related]

  • 5. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X, Wu P, Sun X, Li W, Wan H, Yu J, Xing L.
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [Abstract] [Full Text] [Related]

  • 6. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R, Halama J, Bova D, Sethi A, Emami B.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):720-6. PubMed ID: 17293230
    [Abstract] [Full Text] [Related]

  • 7. [¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.
    Petit SF, van Elmpt WJ, Oberije CJ, Vegt E, Dingemans AM, Lambin P, Dekker AL, De Ruysscher D.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):698-705. PubMed ID: 20884128
    [Abstract] [Full Text] [Related]

  • 8. Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
    Aristophanous M, Berbeco RI, Killoran JH, Yap JT, Sher DJ, Allen AM, Larson E, Chen AB.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e99-105. PubMed ID: 21377285
    [Abstract] [Full Text] [Related]

  • 9. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Hölscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M.
    Radiother Oncol; 2008 Sep 01; 88(3):335-41. PubMed ID: 18514339
    [Abstract] [Full Text] [Related]

  • 10. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, Abdel-Dayem H, Guirguis A, Ross P, Evola A.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1016-23. PubMed ID: 15979817
    [Abstract] [Full Text] [Related]

  • 11. [The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
    Lõcsei Z, Hideghéty K, Farkas R, Bellyei S, Sárosi V, Sebestyén K, Sebestyén Z, Kovács P, Mangel L.
    Magy Onkol; 2011 Nov 15; 55(4):274-80. PubMed ID: 22128310
    [Abstract] [Full Text] [Related]

  • 12. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
    Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.
    Cancer Radiother; 2005 Sep 15; 9(5):304-15. PubMed ID: 16087377
    [Abstract] [Full Text] [Related]

  • 13. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
    Bollineni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):e551-5. PubMed ID: 22417800
    [Abstract] [Full Text] [Related]

  • 14. Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
    Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Péchoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G, Giraud P.
    Lancet Oncol; 2024 Sep 15; 25(9):1176-1187. PubMed ID: 39134086
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [18F]FDG and [18F]Fluoromisonidazole PET/CT in Non-small-cell Lung Cancer Patients.
    Thureau S, Modzelewski R, Bohn P, Hapdey S, Gouel P, Dubray B, Vera P.
    Mol Imaging Biol; 2020 Jun 15; 22(3):764-771. PubMed ID: 31432388
    [Abstract] [Full Text] [Related]

  • 16. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.
    Thureau S, Dubray B, Modzelewski R, Bohn P, Hapdey S, Vincent S, Anger E, Gensanne D, Pirault N, Pierrick G, Vera P.
    Radiat Oncol; 2018 Oct 23; 13(1):208. PubMed ID: 30352608
    [Abstract] [Full Text] [Related]

  • 17. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
    Ding X, Li H, Wang Z, Huang W, Li B, Zang R, Sun H, Yi Y.
    Technol Cancer Res Treat; 2013 Jun 23; 12(3):251-7. PubMed ID: 23289475
    [Abstract] [Full Text] [Related]

  • 18. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, Kirsch CM.
    J Nucl Med; 2005 Aug 23; 46(8):1342-8. PubMed ID: 16085592
    [Abstract] [Full Text] [Related]

  • 19. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
    Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1098-104. PubMed ID: 19386444
    [Abstract] [Full Text] [Related]

  • 20. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):78-86. PubMed ID: 15093902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.